Physiological coagulation can be maintained in extracorporeal circulation by means-of shed blood separation and coating

被引:33
作者
Albes, JM
Stöhr, IM
Kaluza, M
Siegemund, N
Schmidt, D
Vollandt, R
Wahlers, T
机构
[1] Univ Hosp Jena, Dept Cardiovasc & Vasc Surg, Jena, Germany
[2] Univ Leipzig, Dept Internal Med, Leipzig, Germany
[3] Univ Hosp Jena, Dept Clin Chem, Jena, Germany
[4] Univ Hosp Jena, Dept Med Stat Informat & Documentat, Jena, Germany
关键词
D O I
10.1016/S0022-5223(03)00958-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Conventional extracorporeal circulation results in an activation of coagulation cascades. Coating of extracorporeal circulation tubes as well as avoidance of shed blood recirculation have been shown to reduce these phenomena. We evaluated a new shed blood separation system (AVANT D 970) utilizing a coated cardiopulmonary bypass tube system (PHISIO). Methods: Forty patients (62 +/- 10 years) underwent isolated coronary revascularization. Four groups (n = 10/group) were defined: no extracorporeal circulation, conventional uncoated extracorporeal circulation, uncoated extracorporeal circulation with shed blood separation, and coated extracorporeal circulation with shed blood separation. Thrombin-antithrombin complex and free Hb were analyzed and statistically compared. Results: Conventional extracorporeal circulation exhibited the highest intraoperative activation of coagulation (thrombin-antithrombin complex: extracorporeal circulation, 31.1 +/- 15.8 mug/L; uncoated extracorporeal circulation with shed blood separation, 15.3 +/- 7.8 mug/L; coated extracorporeal circulation with shed blood separation, 8.1 +/- 4.8 mug/L; no extracorporeal circulation, 2.4 +/- 0.6 mug/L; P <.05 extracorporeal circulation vs all others) and red blood cell damage (free Hb: extracorporeal circulation, 16.8 +/- 11.4 mumol/L; uncoated extracorporeal circulation with shed blood separation, 10.3 +/- 3.5 mumol/L; coated extracorporeal circulation with shed blood separation, 6.8 +/- 2.9 mumol/L; no extracorporeal circulation, 3.4 +/- 1.1 mumol/L; P <.05 extracorporeal circulation vs no extracorporeal circulation, coated extracorporeal circulation with shed blood separation). Coated extracorporeal circulation with shed blood separation showed only slight activation and cell trauma, which did not differ significantly from no extracorporeal circulation. Conclusions: Combination of coating and avoidance of shed blood recirculation maintained physiological coagulation levels and markedly reduced red blood cell trauma in extracorporeal circulation procedures. These combined modalities may therefore offer an alternative for off-pump procedures in patients with contraindications for conventional extracorporeal circulation.
引用
收藏
页码:1504 / 1512
页数:9
相关论文
共 26 条
[1]   Removal of activated complement from shed blood: comparison of high- and low-dilutional haemofiltration [J].
Arnestad, JP ;
Hyllner, M ;
Bengtson, JP ;
Tylman, M ;
Mollnes, TE ;
Bengtsson, A .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1998, 42 (07) :811-815
[2]   SAFETY AND THERAPEUTIC EFFECTIVENESS OF REINFUSED SHED BLOOD AFTER OPEN-HEART-SURGERY [J].
AXFORD, TC ;
DEARANI, JA ;
RAGNO, G ;
MACGREGOR, H ;
PATEL, MA ;
VALERI, CR ;
KHURI, SF .
ANNALS OF THORACIC SURGERY, 1994, 57 (03) :615-622
[3]  
Bergmann Per, 1994, Perfusion, V9, P35, DOI 10.1177/026765919400900106
[4]   Duroflo II heparin bonding does not attenuate cytokine release or improve pulmonary function [J].
Butler, J ;
Murithi, EW ;
Pathi, VL ;
MacArthur, KJD ;
Berg, GA .
ANNALS OF THORACIC SURGERY, 2002, 74 (01) :139-142
[5]   Phosphorylcholine coating of extracorporeal circuits provides natural protection against blood activation by the material surface [J].
De Somer, F ;
François, K ;
van Oeveren, W ;
Poelaert, J ;
De Wolf, D ;
Ebels, T ;
Van Nooten, G .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2000, 18 (05) :602-606
[6]   TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND FIBRIN MONOMERS SYNERGISTICALLY CAUSE PLATELET DYSFUNCTION DURING RETRANSFUSION OF SHED BLOOD AFTER CARDIOPULMONARY BYPASS [J].
DEHAAN, J ;
SCHONBERGER, J ;
HAAN, J ;
VANOEVEREN, W ;
EIJGELAAR, A .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1993, 106 (06) :1017-1023
[7]   Aprotinin in coronary operation with cardiopulmonary bypass: Does "low-dose" aprotinin inhibit the inflammatory response? [J].
Englberger, L ;
Kipfer, B ;
Berdat, PA ;
Nydegger, UE ;
Carrel, TP .
ANNALS OF THORACIC SURGERY, 2002, 73 (06) :1897-1904
[8]   Involvement of glycoprotein VI in platelet thrombus formation on both collagen and von Willebrand factor surfaces under flow conditions [J].
Goto, SY ;
Tamura, N ;
Handa, S ;
Arai, M ;
Kodama, K ;
Takayama, H .
CIRCULATION, 2002, 106 (02) :266-272
[9]   Reducing the post-pump syndrome by using heparin-coated circuits, steroids, or aprotinin [J].
Harig, F ;
Feyrer, R ;
Mahmoud, FO ;
Blum, U ;
von der Emde, J .
THORACIC AND CARDIOVASCULAR SURGEON, 1999, 47 (02) :111-118
[10]   Activation of coagulation and fibrinolysis during cardiothoracic operations [J].
Hunt, BJ ;
Parratt, RN ;
Segal, HC ;
Sheikh, S ;
Kallis, P ;
Yacoub, M .
ANNALS OF THORACIC SURGERY, 1998, 65 (03) :712-718